TGIFF (1933 Industries) Earnings Yield (Joel Greenblatt) %: -0.30% (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is 1933 Industries Earnings Yield (Joel Greenblatt) %?

1933 Industries TGIFF -20.34% Earnings Yield (Joel Greenblatt) % is -0.30% as of Apr. 2026. The stock has 2 warning signs investors should review. Among 1,007 Drug Manufacturers companies, 1933 Industries ranks worse than 69.91% on this metric.

1933 Industries's Enterprise Value for the quarter that ended in Apr. 2026 was $14.96 Mil. 1933 Industries's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 was $-0.05 Mil. 1933 Industries's Earnings Yield (Joel Greenblatt) for the quarter that ended in Apr. 2026 was -0.30%.

The historical rank and industry rank for 1933 Industries's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

TGIFF' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -74.94   Med: -12.68   Max: 5.15
Current: -0.3

During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of 1933 Industries was 5.15%. The lowest was -74.94%. And the median was -12.68%.

TGIFF's Earnings Yield (Joel Greenblatt) % is ranked worse than
69.91% of 1007 companies
in the Drug Manufacturers industry
Industry Median: 3.25 vs TGIFF: -0.30

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. 1933 Industries's Forward Rate of Return (Yacktman) % for the quarter that ended in Apr. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


1933 Industries  (OTCPK:TGIFF) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


1933 Industries Earnings Yield (Joel Greenblatt) % Related Terms


1933 Industries Earnings Yield (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for 1933 Industries's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

1933 Industries Earnings Yield (Joel Greenblatt) % Chart

1933 Industries Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.95 -57.14 -56.18 -8.86 3.20

1933 Industries Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.05 3.20 4.10 2.51 -0.30

TGIFF vs ZTS: Earnings Yield (Joel Greenblatt) % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, 1933 Industries's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


1933 Industries Earnings Yield (Joel Greenblatt) % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 1933 Industries's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where 1933 Industries's Earnings Yield (Joel Greenblatt) % falls into.



1933 Industries Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

1933 Industriess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jul. 2025 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=0.514/15.43485
=3.33 %

1933 Industries's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.05 Mil.


What does a Earnings Yield (Joel Greenblatt) % of -0.30% mean?
1933 Industries (TGIFF) has a Earnings Yield (Joel Greenblatt) % of -0.30% as of Apr. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on 1933 Industries and its competitors. According to the industry distribution chart, 1933 Industries ranks #704 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 69.9%.
Is 1933 Industries' Earnings Yield (Joel Greenblatt) % too high?
1933 Industries' current Earnings Yield (Joel Greenblatt) % is -0.30%. Based on the distribution chart, 1933 Industries ranks #704 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does 1933 Industries' Earnings Yield (Joel Greenblatt) % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, 1933 Industries ranks #704 out of 1007 companies for Earnings Yield (Joel Greenblatt) %. This places 1933 Industries in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Drug Manufacturers company?
The median Earnings Yield (Joel Greenblatt) % among Drug Manufacturers companies is 3.25, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on 1933 Industries and its competitors. For the Drug Manufacturers industry, the median Earnings Yield (Joel Greenblatt) % is 3.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 1933 Industries's current Earnings Yield (Joel Greenblatt) % is -0.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1933 Industries stock overvalued right now?
Based on GuruFocus' analysis, 1933 Industries (TGIFF) is currently considered Possible Value Trap. The current Earnings Yield (Joel Greenblatt) % is -0.30%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For 1933 Industries (TGIFF), the current Earnings Yield (Joel Greenblatt) % is -0.30% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

1933 Industries Business Description

Other Exchanges TGIF:Canada
Address 1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 2E9
1933 Industries Inc is a vertically integrated cannabis company. The company is focused on the cultivation and manufacturing of cannabis consumer-branded goods. The Company operates in three segments, referred to as AMA, Infused MFG, and Corporate. AMA is focused on the cultivation and sale of medical and adult-use cannabis products, and Infused MFG is focused on the manufacturing of hemp-derived CBD products. The majority of revenue is generated from the AMA segment. The operations of AMA and Infused MFG are located in the United States. All revenues are earned in the United States.